Novogene Co., Ltd. Hits Day High with Strong 6.51% Intraday Surge

Novogene Co., Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 6.51% on May 25, 2026. The stock reached an intraday high of CNY 15.72, reflecting a strong performance compared to the China Shanghai Composite, which only increased by 0.96% on the same day. Over the past week, Novogene has outperformed the benchmark with a 5.3% gain, and its one-month performance stands at 11.03%. However, the company has faced challenges in the long term, with a notable decline of 50.77% over the past three years and 68.74% over the last five years. Despite these setbacks, the year-to-date performance of 18.22% indicates some recovery relative to the China Shanghai Composite's 4.63%. Key financial metrics reveal a P/E ratio of 36.00 and a return on equity of 5.86%. The company has also reported a low interest coverage ratio of 5,463.22, suggesting a cautious approach to its financial health. Overall, Novogene Co., Ltd. continues to navigate a complex market landscape while demonstrating notable short-term gains.